课题基金 / 基金详情

Molecular Mechanisms of Lymphangiogenesis in Development and Disease.

Molecular Mechanisms of Lymphangiogenesis in Development and Disease.
发育和疾病中淋巴管生成的分子机制。
批准号:
nhmrc : 453493
负责人:
A/Pr Natasha Harvey
金额:
$20.26万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31

项目摘要

项目成果

A/Pr Natasha Harvey的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lymphatic vessels are a vital component of the cardiovascular system and serve several functions critical to embryonic development and adult health. These include: 1. The uptake, transport and return to the bloodstream of tissue fluid and protein. 2. The uptake and transport of lipids from the digestive tract. 3. The transport of cells of the immune system that fight infection. Abnormalities in the development and function of lymphatic vessels are associated with a large number of human diseases. These include primary and secondary lymphoedema, inflammatory diseases such as psoriasis, rheumatoid arthritis and and asthma, and malignancies of the lymphatic vessels such as lymphangiosarcoma and Kaposi's sarcoma. Lymphatic vessels are also critical for the progression of many forms of cancer, by virtue of the fact that tumour cells exploit lymphatic vessels as a transport route for metastases. Diseases in which lymphatic vessels are involved therefore impact on a significant proportion of the Australian population. Our current knowledge of the mechanisms by which the lymphatic vascular network is constructed during embryonic development, and deregulated in disease states, is extremely limited. Once the molecular mechanisms of disease origin are established, much needed novel therapeutics to treat patients suffering from lymphatic vascular diseases can be designed. Treatments targeted to prevent the aberrant growth of lymphatic vessels are vital to halt tumour metastasis and the progress of inflammatory diseases, while treatments targeted to stimulate the development of new lymphatic vessels are necessary to treat diseases in which lymphatic vessels are hypoplastic, such as lymphoedema. This project aims to advance our understanding of lymphatic vascular development and function, in order to provide the opportunity to benefit patients suffering from all spectrums of lymphatic vascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the role of a novel transcriptional enhancer element in regulation of Prox1 expression and endothelial cell identity.
  • 批准号:
    nhmrc : 1146706
  • 项目类别:
    Project Grants
  • 资助金额:
    $47.14万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Natasha Harvey
  • 依托单位:
Defining the role of a novel transcriptional enhancer element in regulation of Prox1 expression and endothelial cell identity.
  • 批准号:
    nhmrc : GNT1146706
  • 项目类别:
    Project Grants
  • 资助金额:
    $69.71万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Natasha Harvey
  • 依托单位:
Understanding how GATA2 controls lymphatic vessel valve development
  • 批准号:
    nhmrc : GNT1146800
  • 项目类别:
    Project Grants
  • 资助金额:
    $68.83万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Natasha Harvey
  • 依托单位:
Trafficking mechanisms governing receptor availability for signalling
  • 批准号:
    nhmrc : 1146087
  • 项目类别:
    Project Grants
  • 资助金额:
    $35.63万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Natasha Harvey
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位: